In a typical stroke imaging protocol, patients receive a non-contrast computed tomography (CT) scan to potentially confirm the presence of an infarct but, more importantly, to rule out an intracranial hemorrhage in order to administer tissue plasminogen activator (tPA). Here, PLAT is linked to intracranial hemorrhage.